Cargando…

IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients

(1) Background: The high-grade neuroepithelial tumor of the central nervous system with BCOR alteration (HGNET-BCOR) is a highly malignant tumor. Preclinical models and molecular targets are urgently required for this cancer. Previous data suggest a potential role of insulin-like growth factor (IGF)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vewinger, Nadine, Huprich, Sabrina, Seidmann, Larissa, Russo, Alexandra, Alt, Francesca, Bender, Hannah, Sommer, Clemens, Samuel, David, Lehmann, Nadine, Backes, Nora, Roth, Lea, Harter, Patrick N., Filipski, Katharina, Faber, Jörg, Paret, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627083/ https://www.ncbi.nlm.nih.gov/pubmed/31234291 http://dx.doi.org/10.3390/ijms20123027

Ejemplares similares

Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy
por: Paret, Claudia, et al.
Publicado: (2017)

Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy
por: Paret, Claudia, et al.
Publicado: (2016)

Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor
por: Russo, Alexandra, et al.
Publicado: (2019)

MODL-04. MODELING CNS HGNET-BCOR PATHOGENESIS USING NEURAL STEM CELLS
por: Nakata, Satoshi, et al.
Publicado: (2020)

Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma
por: Wingerter, Arthur, et al.
Publicado: (2021)

Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
por: Beck, Olaf, et al.
Publicado: (2020)

Tumor Lipids of Pediatric Papillary Renal Cell Carcinoma Stimulate Unconventional T Cells
por: Lehmann, Nadine, et al.
Publicado: (2020)

Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes
por: Łastowska, Maria, et al.
Publicado: (2020)

Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1
por: Paret, Claudia, et al.
Publicado: (2021)

HGG-03. THE GLYCOSPHINGOLIPIDS METABOLISM IS A NOVEL TARGET IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA
por: Paret, Claudia, et al.
Publicado: (2021)

Pediatric methylation class HGNET-MN1: unresolved issues with terminology and grading
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2019)

BCOR involvement in cancer
por: Astolfi, Annalisa, et al.
Publicado: (2019)

PATH-18. HIGH-GRADE NEUROEPITHELIAL TUMOR (HGNET) IN A PEDIATRIC CASE-SERIES
por: Sanders, Felipe Hada, et al.
Publicado: (2020)

Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL
por: Ziegler, Nicole, et al.
Publicado: (2023)

Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies
por: Tanaka, Tomoyuki, et al.
Publicado: (2017)

CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis
por: Fischer, Jeannette, et al.
Publicado: (2017)

Intra‐ and extra‐cranial BCOR‐ITD tumours are separate entities within the BCOR ‐rearranged family
por: Bouchoucha, Yassine, et al.
Publicado: (2022)

ETMR-03. Intra- and extra-cranial BCOR-ITD tumours are separate entities within the BCOR-rearranged family
por: Bouchoucha, Yassine, et al.
Publicado: (2022)

Paediatric BCOR ‐associated sarcomas with a novel long spliced internal tandem duplication of BCOR exon 15
por: Goh, Jian Yuan, et al.
Publicado: (2022)

Molecular Identification and In Silico Protein Analysis of a Novel BCOR-CLGN Gene Fusion in Intrathoracic BCOR-Rearranged Sarcoma
por: Chang Chien, Yi-Che, et al.
Publicado: (2023)

GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype
por: Paret, Claudia, et al.
Publicado: (2022)

Recurrent HGNET-MN1 altered (astroblastoma MN1-altered) of the foramen magnum: Case report and molecular classification
por: Gopakumar, Sricharan, et al.
Publicado: (2022)

BCoR-L1 variation and breast cancer
por: Lose, Felicity, et al.
Publicado: (2007)

Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis
por: Kelly, Madison J., et al.
Publicado: (2019)

Rare Case of BCOR::CCNB3 Sarcoma of Bone
por: Arai, Yumi, et al.
Publicado: (2023)

Oculofaciocardiodental syndrome caused by a novel BCOR variant
por: Yamashita, Tomoyo, et al.
Publicado: (2023)

The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of “CNS tumors with BCOR internal tandem duplication”
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2020)

Apoptosis of ileal crypt epithelia after allogeneic bone marrow transplantation without graft-versus-host disease
por: Kreft, Andreas, et al.
Publicado: (2015)

ETMR-11. Transcriptional changes upon knockdown of alteredBCOR/BCORL1 transcripts in preclinical models of CNS embryonal tumors with BCOR-related alterations
por: Piontek, Martin, et al.
Publicado: (2022)

Correction: BCoR-L1 variation and breast cancer
por: Lose, Felicity, et al.
Publicado: (2008)

BCOR regulates mesenchymal stem cell function by epigenetic mechanisms
por: Fan, Zhipeng, et al.
Publicado: (2009)

Fusions involving BCOR and CREBBP are rare events in infiltrating glioma
por: Pisapia, David J., et al.
Publicado: (2020)

The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma
por: Kang, Jin Hyun, et al.
Publicado: (2021)

Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney
por: Roy, Angshumoy, et al.
Publicado: (2015)

BCOR-CCNB3 Fusions Are Frequent in Undifferentiated Sarcomas of Male Children
por: Peters, Tricia L., et al.
Publicado: (2014)

Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications
por: Kommoss, Felix KF, et al.
Publicado: (2020)

NTRK3 Overexpression in Undifferentiated Sarcomas with YWHAE and BCOR Genetic Alterations
por: Kao, Yu-Chien, et al.
Publicado: (2020)

Specific and Sensitive Diagnosis of BCOR-ITD in Various Cancers by Digital PCR
por: Barets, Doriane, et al.
Publicado: (2021)

BCOR mutation and TLS-ERG expression in acute myeloid leukemia with monoclonal immunoglobulinemia
por: Jin, Jingxia, et al.
Publicado: (2019)

Detection of BCOR gene rearrangement in Ewing-like sarcoma: an important diagnostic tool
por: Li, Lan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5jqldbuuubju183ihflt4756qi